risankizumab-rzaa
Used for Psoriasis
NowPatient can significantly lower the cost* of your prescription medication by providing free access to drug coupons, savings cards, patient assistance programs and other out of pocket discount programs. Whether you’re insured, uninsured, or underinsured, we empower you with transparency and cost-saving tools to make your risankizumab-rzaa more affordable.
Manufactured by various FDA-approved generic manufacturers.
*You can pay as little as $0 per fill using Drug Coupons or Patient Assistance Programs. Subject to applicability & eligibility requirements.
Start Saving Today!
Lower the Cost of Your risankizumab-rzaa Prescription
Rx Advantage Card
Our savings card can be used in over 65,000 pharmacies and could save you up to 90% on the cost of your medication. Suitable for insured, underinsured and uninsured individuals. This is not health insurance and cannot be used in conjunction with insurance.
- UnavailableN/AManufactured byN/APowered by
Canadian Online Pharmacy
Our trusted licensed Canadian pharmacy partner, Prescription Help, is on hand to offer great savings on the cost of your medications.
Unavailable - Unavailable
Drug Coupons
For those who are commercially insured, drug manufacturer coupons can help reduce your out-of-pocket costs. Eligible for commercially insured only.
Unavailable - Unavailable
Patient Assistance Programs
Patient assistance programs (PAPs) are sponsored by pharmaceutical companies and can mean you can obtain your medications at no cost to you. Suitable for insured, underinsured and uninsured individuals who are financially constrained.
Unavailable
MEDICAL INFORMATION
risankizumab-rzaa Key Facts
What dosages is risankizumab-rzaa available in?
risankizumab-rzaa is available as follows:
- Subcutaneous injection
- 150 mg/mL in each single-dose prefilled pen
- 90 mg/mL in each single-dose prefilled syringe
- 150 mg/mL in each single-dose prefilled syringe
- 180 mg/1.2 mL (150 mg/mL) in each single-dose prefilled cartridge
- 360 mg/2.4 mL (150 mg/mL) in each single-dose prefilled cartridge
- Intravenous infusion 600 mg/10 mL (60 mg/mL) in each single-dose vial
What is risankizumab-rzaa used for?
- risankizumab-rzaa is a monoclonal antibody that is used to treat:
- Moderate-to-severe plaque psoriasis
- Psoriatic arthritis
- Moderate-to-severe Crohn’s disease
How does risankizumab-rzaa work?
risankizumab-rzaa is a monoclonal antibody that works as an interleukin antagonist. It attaches to certain proteins in your immune system called interleukin-23 (IL-23) that play a role in causing inflammation. This stops the proteins from getting turned on, which helps lower inflammation.
How do I take risankizumab-rzaa?
- risankizumab-rzaa is dosed as follows:
- Plaque psoriasis and psoriatic arthritis: The typical starting dose is 150 mg injected under the skin once every month for the first 2 doses. Then, it’s given once every 3 months.
- Crohn’s disease: The typical starting dose is 600 mg infused through the veins (intravenous or IV) once every month for the first 3 doses. Then one month later, the dose changes to 180 mg or 360 mg injected under the skin that’s given once every 2 months.
Is it safe for me to take risankizumab-rzaa?
risankizumab-rzaa is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you. risankizumab-rzaa is contraindicated in patients with a history of serious
hypersensitivity reaction to risankizumab-rzaa or any of the excipients.
risankizumab-rzaa Common Side Effects
- Common side effects of risankizumab-rzaa:
- Upper respiratory infections
- Joint pain
- Headache
- Tiredness
- Injection site reaction (e.g., bruising, redness, pain, swelling, itching, warmth, bleeding, irritation)
risankizumab-rzaa Serious Side Effects
Serious side effects are rare with risankizumab-rzaa. Contact your healthcare provider immediately if you experience any of the following.
- Serious allergic reactions: difficulty breathing; hives; swelling of your face, lips, tongue, or throat
Infection: fever; cough; difficulty breathing; diarrhea; weakness; sweating; chills; scaly, itchy, or burning skin
Effects of other drugs, drug classes and over-the-counter products on risankizumab-rzaa
- There are no major drug interactions listed for risankizumab-rzaa. However, always let your physician and pharmacist know about any other medications or supplements (including prescribed and over-the-counter medications, vitamins, and dietary or herbal supplements) that you are currently taking
Who makes risankizumab-rzaa?
Various FDA-approved generic manufacturers
Is risankizumab-rzaa safe in pregnancy?
Although there are no data on risankizumab-rzaa, monoclonal antibodies can be actively transported across the placenta, and risankizumab-rzaa may cause immunosuppression in the in utero-exposed infant. risankizumab-rzaa should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. There is a pregnancy exposure registry that monitors outcomes in women who become pregnant while treated with risankizumab-rzaa. Patients should be encouraged to enroll by calling 1-877-302-2161 or
visiting glow pregnancy registry
The FDA's medical product safety reporting program for health professionals, patients and consumers.
Learn more about reporting side effects in the USDrug Savings Guide
A Practical Guide to Saving Money and Receiving Support With Prescription Drug Costs
How can NowPatient help me to lower the cost of my risankizumab-rzaa prescription?
After you create a FREE account with NowPatient, you will have access to 4 programs that can help lower the cost of your risankizumab-rzaa prescription
Applicability to each program will be dependent on your insurance status.
How do the NowPatient risankizumab-rzaa savings programs work?
After you have created your FREE account with NowPatient, you can access the various programs from your account dashboard. Each program has clear instructions on how to check your eligibility. You can see how the process works by clicking on the feature link below and seeing the ‘How it works’ steps.
Drug Coupon and Patient Assistance Programs require an eligibility quiz to be completed.
Are the NowPatient risankizumab-rzaa savings programs suitable for everyone, regardless of insurance status?
No. Each program has its own eligibility and applicability requirements. The table below shows if a program is available to you, based on your insurance status.
| Rx Advantage Card* for risankizumab-rzaa | Canadian Prescription Savings* for risankizumab-rzaa | risankizumab-rzaa Drug Coupon* | risankizumab-rzaa Patient Assistance Program* | |
| Insured (federal, state or government) | Available | Available | Not Available | Available If Offered by Pharmaceutical Company |
| Insured (Commercial or Private) | Available | Available | Available If Offered by Pharmaceutical Company | Available If Offered by Pharmaceutical Company |
| Uninsured | Available | Available | Not Available | Available If Offered by Pharmaceutical Company |
| Insured but without pharmacy benefit or drug coverage | Available | Available | Not Available | Available If Offered by Pharmaceutical Company |
*This is not insurance.
Are the NowPatient drug savings programs suitable for brand and generic versions of risankizumab-rzaa?
No. Each program has applicability requirements. Please see below
| Rx Advantage Card* for risankizumab-rzaa | Canadian Prescription Savings* for risankizumab-rzaa | risankizumab-rzaa Drug Coupon* | risankizumab-rzaa Patient Assistance Program* | |
| Brand | Yes | Yes | Yes, If Offered by Pharmaceutical Company | Yes, If Offered by Pharmaceutical Company |
| Generic | Yes | Yes | No | No |
*This is not insurance.
If you have Medicare Part D or Medicare Advantage and none of the risankizumab-rzaa savings options are applicable or affordable for me, what can you do?
If you are insured with Medicare and the risankizumab-rzaa drug savings options are not applicable to you and still remain unaffordable, then you can check Medicaid eligibility in your state by following the instructions at HealthCare.gov.
The government site is easy to use and after you have selected your state, it will navigate you to the appropriate contact point to make the application. State Medicaid programs may cover the full cost of your medication.
People who qualify for both Medicare and Medicaid are called ‘dual eligibles’.
If you are denied Medicaid for risankizumab-rzaa, and you are still unable to afford your copay or co-insurance element (for example if you are in the coverage gap or Donut Hole) then you may be eligible for a federal support program like Low Income Subsidy. To be eligible for Low Income Subsidy, you need to be a resident in one of the 50 States or the District of Columbia. You can check eligibility online at SSA Medicare D Extra Help. You can also call Social Security at 1-800-772-1213 (TTY 1-800-325-0778).
I am uninsured or underinsured and none of the risankizumab-rzaa prescription saving options are applicable or affordable for me, what can I do?
If you are uninsured or underinsured (for example, risankizumab-rzaa is not covered by your plan) and the drug savings options are not applicable or still unaffordable, then you can check Medicaid eligibility in your state by following the instructions at HealthCare.gov.
The government site is easy to use and you can select your state and it will navigate you to the appropriate contact point to make the application. State Medicaid programs may cover the full cost of your medication.
If you are denied and all else fails, and if you have been prescribed risankizumab-rzaa for an FDA-approved indication, you can call the pharmaceutical company to see if they have any other assistance programs.
I am commercially or privately insured and none of the risankizumab-rzaa prescription saving options are applicable or affordable for me, what can I do?
If your medication is not covered by your plan, you can appeal your insurance company’s decision. Sometimes, a formal appeal can result in the drug being covered if it is deemed medically necessary.
If you cannot afford your copay contribution, then you can check Medicaid eligibility in your state by following the instructions at HealthCare.gov.
However, being privately insured might complicate your eligibility for Medicaid, as having private insurance may be considered in the financial eligibility assessment.
The government site is easy to use and you can select your state and it will navigate you to the appropriate contact point to make the application. If you qualify, state Medicaid may cover the full cost of your medication.
If I have federal, state or commercial insurance and none of the risankizumab-rzaa prescription saving options are applicable or affordable for me, are there any other support organisations that can help me with my co-insurance or copay contributions?
If you have already tried Medicaid and received a denial letter or if you are insured with Medicare and have been denied Low-Income Subsidy, then you can try one of the following organizational support programs:
1. Patient Access Network Foundation (PAN) assistance for risankizumab-rzaa
If you are having trouble paying for your risankizumab-rzaa medication due to unaffordable copays or deductibles, the Patient Access Network Foundation (PAN), may be able to assist you. To qualify for PAN assistance for risankizumab-rzaa you will need to meet one or all of the following criteria:
- Your income is below 400% of the federal poverty level
- risankizumab-rzaa is prescribed for an approved FDA indication
- You live in and receive treatment in the United States or U.S. territories, even if you do not have U.S. citizenship
- You have Medicare insurance coverage that covers risankizumab-rzaa
- If risankizumab-rzaa is listed on PAN’s list of covered medications
You can check the Patient Access Network Foundation Website for more information.
2. HealthWell Foundation Copay Program for risankizumab-rzaa
If you are having trouble paying for your risankizumab-rzaa medication due to unaffordable copays or deductibles, the HealthWell Foundation Copay Program may be able to assist you. To qualify for assistance for risankizumab-rzaa you will need to meet the following criteria:
- You live in and are being treated in the United States
- You are insured and your plan covers risankizumab-rzaa
- If risankizumab-rzaa is listed on the HealthWell Foundation’s list of covered medications
You can check the HealthWell Foundation Website for more information.
3. Patient Advocate Foundation Co-Pay Relief Program for risankizumab-rzaa
Patient Advocate Foundation’s Co-Pay Relief program exists to help reduce the financial distress you or your family may face when paying for your risankizumab-rzaa treatment. If you qualify and can demonstrate the need, the foundation will provide you with direct payment covering co-pays, co-insurance, and deductibles. To qualify for assistance for risankizumab-rzaa you will need to meet the following criteria:
- You must be currently insured and have coverage for risankizumab-rzaa
- You must have a confirmed diagnosis and treatment plan
- You must reside and receive treatment in the United States
- Your Income must fall at or below 300% or 400% of the Federal Poverty Guideline (FPG) with consideration for the Cost of Living Index (COLI) and number in the household
- Applications can also be completed by contacting the program sponsor, toll-free at 866-512-3861.
You can check the Patient Advocate Foundation Website for more information.
Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.